Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma-Reference-Cited by-同舟云学术

Unraveling the extracellular matrix-tumor cell interactions to aid better targeted therapies for neuroblastoma

Published:2021-10 Issue: Volume:608 Page:121058
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Burgos-Panadero Rebeca,El Moukhtari Souhaila H.,Noguera Inmaculada,Rodríguez-Nogales Carlos,Martín-Vañó Susana^ORCID,Vicente-Munuera Pablo^ORCID,Cañete Adela,Navarro Samuel,Blanco-Prieto María J^ORCID,Noguera Rosa

Funder

Fundación Científica de la Asociación Española Contra el Cáncer

ISCIII

ERDF

CIBER

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference72 articles.

1. Aaboe, M., Offersen, B. V, Christensen, A., Andreasen, P.A., 2003. Vitronectin in human breast carcinomas. Biochim. et Biophys. Acta (BBA) – Mol. Basis Dis. 638, 72–82. https://doi.org/10.1016/S0925-4439(03)00059-0.

2. Bäuerle, T., Komljenovic, D., Merz, M., Berger, M.R., Goodman, S.L., Semmler, W., 2011. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. Int. J. Cancer 128, 2453–2462. https://doi.org/https://doi.org/10.1002/ijc.25563.

3. Berthold, F., Faldum, A., Ernst, A., Boos, J., Dilloo, D., Eggert, A., Fischer, M., Frühwald, M., Henze, G., Klingebiel, T., Kratz, C., Kremens, B., Krug, B., Leuschner, I., Schmidt, M., Schmidt, R., Schumacher-Kuckelkorn, R., von Schweinitz, D., Schilling, F.H., Theissen, J., Volland, R., Hero, B., Simon, T., 2020. Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR. Annals Oncol. 31, 422–429. https://doi.org/https://doi.org/10.1016/j.annonc.2019.11.011.

4. Brodeur, G.M., Sekhon, G.S., Goldstein, M.N., 1977. Chromosomal aberrations in human neuroblastomas. Cancer 40, 2256–2263. https://doi.org/https://doi.org/10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1.

5. Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma;Burgos-Panadero;BMC Cancer,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?;International Journal of Molecular Sciences;2024-08-10

2. Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma;Neoplasia;2024-06

3. An Update on Emergent Nano-Therapeutic Strategies against Pediatric Brain Tumors;Brain Sciences;2024-02-18

4. Biosafety evaluation of etoposide lipid nanomedicines in C. elegans;Drug Delivery and Translational Research;2024-02-16

5. Impact of pre-treatment extracellular volume fraction measured by computed tomography on response of primary lesion to preoperative chemotherapy in abdominal neuroblastoma;Clinics;2024-01